RB394
目录号 : GC15909
A dual modulator of sEH and PPARγ
Cas No.:1830320-32-5
Sample solution is provided at 25 µL, 10mM.
;)
_1-7.$$$37316672@70.jpg');)
;)
;)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
;)
;)
;)
_1124-1138.$$$35908550@30.jpg');)
_766-780.$$$37100057@30.jpg');)
_418-432.$$$36893736@30.jpg');)
_240-255.$$$35108512@29.jpg');)
_533-545.$$$36543525@28.jpg');)
_264-276.$$$36600053@22.jpg');)
_2214998.$$$@0.jpg');)
RB394 is an orally bioavailable and dual modulator of soluble epoxide hydrolase (sEH) and PPARγ [1].
Soluble epoxide hydrolase (sEH) is a bifunctional enzyme involved in the in vivo metabolism of endogenous lipid epoxides. The sEH is abundantly expressed in adipose tissue. sEH is an enzyme of the arachidonic acid cascade, promoting the hydrolysis of cytochrome P450 derived epoxyeicosatrienoic acids (EETs). Endothelial cell-derived EETs activate calcium-activated potassium channels on smooth muscle cells, leading to hyperpolarization and vascular relaxation. PPARγ, a member of the PPAR nuclear receptor family, plays an important role in adipogenesis, regulation of lipid metabolism and glucose homeostasis, and anti-inflammatory processes [1].
RB394 inhibited the activity of sEH with an IC50 of 0.33 μM and activated PPARγ with an EC50 of 0.3 μM. RB394 was inactive at PPARδ and showed 29% activation of PPARαat 10 μM. In mice, treatment with 30 mg/kg RB394 in drinking water for two weeks resulted in a final plasma concentration of ~3 μM. RB394 upregulated the PPARγ target genes, as well as PPARα and PPARδ in mouse livers [1].
References:
[1] Blocher R, Lamers C, Wittmann S K, et al. N-Benzylbenzamides: a novel merged scaffold for orally available dual soluble epoxide hydrolase/peroxisome proliferator-activated receptor γ modulators[J]. Journal of medicinal chemistry, 2015, 59(1): 61-81.
| Cas No. | 1830320-32-5 | SDF | |
| 化学名 | α-ethyl-4-[[[[4-methoxy-2-(trifluoromethyl)phenyl]methyl]amino]carbonyl]-benzenepropanoic acid | ||
| Canonical SMILES | COC1=CC(C(F)(F)F)=C(CNC(C2=CC=C(CC(C(O)=O)CC)C=C2)=O)C=C1 | ||
| 分子式 | C21H22F3NO4 | 分子量 | 409.4 |
| 溶解度 | ≤5mg/ml in ethanol;33mg/ml in DMSO;25mg/ml in dimethyl formamide | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.4426 mL | 12.213 mL | 24.426 mL |
| 5 mM | 0.4885 mL | 2.4426 mL | 4.8852 mL |
| 10 mM | 0.2443 mL | 1.2213 mL | 2.4426 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet